Skip to content
Screener

Zevra Therapeutics, Inc. ZVRA Common Stock Shares Issued

Common Stock Shares Issued at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
193.5M+0.8%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
18.3M+3.4%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$47.34M+15.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
64.8M+29.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
205.9M
ALN
Alnylam PharmaceuticalsALNY
133.7M+2.1%

Other financials

Income statement

See full
Revenue$39.7M+53.3%
Gross profit$38.1M+182%
Operating income$16.8M+124%
Net income$8.8M-88.3%
EPS (diluted)$0.14-88.4%

Balance sheet

See full
Cash & equivalents$145.3M+205%
Total debt$1.5M-97.6%
Total equity$217.7M+85.7%
Total assets$302.7M+18.1%

Cash flow

See full
Operating cash flow$17.0M+573%
CapEx$217.0K+1.9%
Free cash flow$16.8M+541%

Valuation

See full
Market cap$681.73M+6.6%
Enterprise value$537.9M-17.8%
P/E11.7×-230×
P/S-5.3×

Profitability

See full
Gross margin95.5%+23.5pp
Operating margin-103.9%-43.0pp
Net margin42.8%+38.6pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity34.8%+31.3pp
Debt / equity-0.5×
Current ratio5.2×-2.7×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001434647-26-000068
Line itemJune 30,2026December 31,2025
Stockholders’ equity:
Preferred stock:
Undesignated preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2026, or December 31, 2025
Common stock, $0.0001 par value, 250,000,000 shares authorized; 60,917,598 shares issued and 59,341,906 shares outstanding as of June 30, 2026; 58,338,319 shares issued and 56,854,781 shares outstanding as of December 31, 202566
Additional paid-in capital606,264588,458
Treasury stock, at cost(10,983)(10,983)
Accumulated deficit(375,418)(422,060)
Accumulated other comprehensive loss(2,217)(764)

ITEM 1.FINANCIAL STATEMENTS

FAQ

What is Zevra Therapeutics, Inc.'s common stock shares issued?
Zevra Therapeutics, Inc. (ZVRA) reported common stock shares issued of 60.9M in Q2 2026.
How has Zevra Therapeutics, Inc.'s common stock shares issued changed year-over-year?
Zevra Therapeutics, Inc.'s common stock shares issued increased by 7.5% year-over-year, from 56.7M to 60.9M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Zevra Therapeutics, Inc.'s common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude